Literature DB >> 9409478

Local opioid inhibition and morphine dependence of supraoptic nucleus oxytocin neurones in the rat in vivo.

M Ludwig1, C H Brown, J A Russell, G Leng.   

Abstract

1. Single neurones of the rat supraoptic nucleus were recorded during microdialysis of naloxone onto the ventral surface of the nucleus in anaesthetized rats. We used this combination of techniques to test whether the acute or chronic effects of systemically or centrally applied opioids upon oxytocin cell activity were due to actions of the opioids within the nucleus itself. 2. Supraoptic nucleus oxytocin neurones were identified antidromically and by an excitatory response to intravenously injected cholecystokinin. Acute intravenous injection of the kappa-agonist U50488H or the mu-agonist morphine (1-5 mg kg-1) reduced the firing rate of identified oxytocin neurones by 97.7 +/- 4.8% (n = 6) and 94.1 +/- 4.1% (n = 7), respectively. The inhibition by each of these opioids was completely reversed after administration by microdialysis (retrodialysis) of the opioid antagonist naloxone (0.1-1.0 microgram microliter-1 at 2 microliters min-1) onto the exposed ventral surface of the supraoptic nucleus. 3. Retrodialysis of naloxone (0.1-10.0 micrograms microliter-1) onto the supraoptic nucleus of rats made dependent by intracerebroventricular morphine infusion for 5 days increased the firing rate of oxytocin neurones from 0.9 +/- 0.4 to 3.1 +/- 0.7 spikes s-1 (P < 0.05, n = 6). This increase in firing rate from basal was 58.5 +/- 15.1% of that following subsequent intravenously injected naloxone (5 mg kg-1). 4. Thus, the acute inhibition of supraoptic nucleus oxytocin neurones which results from systemic administration of opioid agonists primarily occurs within the supraoptic nucleus itself, since the antagonist naloxone was effective when given into the supraoptic nucleus. Furthermore, oxytocin neurones develop morphine dependence by a mechanism which is distinct from an action on their distant afferent inputs. Nevertheless, withdrawal excitation of these afferent inputs may enhance the magnitude of oxytocin neurone withdrawal excitation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409478      PMCID: PMC1160100          DOI: 10.1111/j.1469-7793.1997.145bc.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  30 in total

1.  Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS.

Authors:  A Mansour; C A Fox; S Burke; H Akil; S J Watson
Journal:  J Chem Neuroanat       Date:  1995-05       Impact factor: 3.052

2.  Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats.

Authors:  K M Pumford; J A Russell; G Leng
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

3.  Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo.

Authors:  C Done; P Silverstone; T Sharp
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

Review 4.  Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus.

Authors:  E J Nestler; M Alreja; G K Aghajanian
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

5.  Organum vasculosum lamina terminalis-evoked postsynaptic responses in rat supraoptic neurones in vitro.

Authors:  C R Yang; V V Senatorov; L P Renaud
Journal:  J Physiol       Date:  1994-05-15       Impact factor: 5.182

6.  Presynaptic actions of morphine: blockade of cholecystokinin-induced noradrenaline release in the rat supraoptic nucleus.

Authors:  T Onaka; S M Luckman; R Guevara-Guzman; Y Ueta; K Kendrick; G Leng
Journal:  J Physiol       Date:  1995-01-01       Impact factor: 5.182

7.  Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.

Authors:  H E Nye; E J Nestler
Journal:  Mol Pharmacol       Date:  1996-04       Impact factor: 4.436

8.  Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.

Authors:  P H Silverstone; C Done; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study.

Authors:  G K Aghajanian; J H Kogan; B Moghaddam
Journal:  Brain Res       Date:  1994-02-04       Impact factor: 3.252

10.  Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the supraoptic nucleus of rat hypothalamus in vitro.

Authors:  K Inenaga; T Nagatomo; K Nakao; N Yanaihara; H Yamashita
Journal:  Neuroscience       Date:  1994-01       Impact factor: 3.590

View more
  11 in total

1.  mu-opioid receptor activation inhibits N- and P-type Ca2+ channel currents in magnocellular neurones of the rat supraoptic nucleus.

Authors:  B L Soldo; H C Moises
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

2.  Apamin increases post-spike excitability of supraoptic nucleus neurons in anaesthetized morphine-naïve rats and morphine-dependent rats: consequences for morphine withdrawal excitation.

Authors:  Philip M Bull; John A Russell; Victoria Scott; Colin H Brown
Journal:  Exp Brain Res       Date:  2011-06-14       Impact factor: 1.972

3.  Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells.

Authors:  L E Johnstone; C H Brown; H K Meeren; C L Vuijst; P J Brooks; G Leng; J A Russell
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

4.  Chronic sugar intake dampens feeding-related activity of neurons synthesizing a satiety mediator, oxytocin.

Authors:  Anaya Mitra; Blake A Gosnell; Helgi B Schiöth; Martha K Grace; Anica Klockars; Pawel K Olszewski; Allen S Levine
Journal:  Peptides       Date:  2010-04-22       Impact factor: 3.750

5.  Effects of the endogenous opioid peptide, endomorphin 1, on supraoptic nucleus oxytocin and vasopressin neurones in vivo and in vitro.

Authors:  N Doi; C H Brown; H D Cohen; G Leng; J A Russell
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

6.  Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat.

Authors:  C H Brown; N P Murphy; G Munro; M Ludwig; P M Bull; G Leng; J A Russell
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

Review 7.  Interplay between the oxytocin and opioid systems in regulating social behaviour.

Authors:  Philip T Putnam; Steve W C Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

Review 8.  Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms.

Authors:  C H Brown; J S Bains; M Ludwig; J E Stern
Journal:  J Neuroendocrinol       Date:  2013-08       Impact factor: 3.627

9.  kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo.

Authors:  C H Brown; M Ludwig; G Leng
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

Review 10.  Somato-dendritic vasopressin and oxytocin secretion in endocrine and autonomic regulation.

Authors:  Colin H Brown; Mike Ludwig; Jeffrey G Tasker; Javier E Stern
Journal:  J Neuroendocrinol       Date:  2020-05-14       Impact factor: 3.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.